| Open Document File Size: 142,42 KBShare Result on Facebook
City Memphis / Curry / Franklin / / Company Accredo Health Group Inc. / IgG / Rare Disease Therapeutics Inc. / DESCRIPTION Anascorp / Transmissible Infectious Agents Anascorp / RDT Part No. Anascorp / Action Anascorp / Rhinorrhea Myalgia Fatigue Cough Diarrhea Lethargy Anascorp / Anascorp / Instituto Bioclon S.A. de C.V. / / Country United States / Mexico / / IndustryTerm contact Rare Disease Therapeutics / manufacturing / manufacturing process / / MedicalCondition ataxia / anaphylactic reaction / allergies / pneumonia / full serum sickness syndrome / arthralgia / Reactions Severe hypersensitivity / nausea / anaphylaxis / fever / vomiting / Severe hypersensitivity / serum sickness / III hypersensitivity / lymphadenopathy / Delayed Allergic Reactions / allergic reactions / Chest tightness / acute hypersensitivity / hypersensitivity / pruritus / rash / infectious agents / joint pain / respiratory distress / / MedicalTreatment intravenous therapy / immunotherapy / / MusicGroup Nausea / / Organization DOSAGE AND ADMINISTRATION / FDA / / Person Mallie J. Antivenom / / / Position physician / / Product diphenhydramine hydrochloride / sodium chloride / epinephrine / glycine / / ProvinceOrState Tennessee / South Carolina / / Technology Pharmacokinetics / / URL www.fda.gov/medwatch / www.bioclon.com.mx / www.raretx.com / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION